Accuresearch Clinical Consulting Inc is categorized under Business Consultants in Collegeville, PA and active since 2010.
Accuresearch Clinical Consulting Inc was established in 2010, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Business Consultants business, which does work in the B2B market, and is classified as a Business Consultants, under code number 541618 by the NAICS.
If you are seeking more information, feel free to contact Dipesh S Pandya at the company’s single location by writing to 33 Greystone Court, Collegeville, Pennsylvania PA 19426 or by phoning (610) 389-5124. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Accuresearch Clinical Consulting Inc |
Contact Person: | Dipesh S Pandya |
Address: | 33 Greystone Court, Collegeville, Pennsylvania 19426 |
Phone Number: | (610) 389-5124 |
Annual Revenue (USD): | $50.000 to $99.999 |
Founded: | 2010 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Business Consultants |
SIC Code: | 8748 |
NAICS Code: | 541618 |
Share This Business: |
Accuresearch Clinical Consulting Inc was started in 2010 to provide professional Business Consultants under the SIC code 8748 and NAICS code 541618. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.
Feel free to contact Dipesh S Pandya for inquiries that concern Accuresearch Clinical Consulting Inc by calling the company number (610) 389-5124, as your correspondence is most welcome. Additionally, the physical location of the single location of Accuresearch Clinical Consulting Inc can be found at the coordinates 40.176504,-75.479752 as well as the street address 33 Greystone Court in Collegeville, Pennsylvania 19426.
For its online presence, you may visit Accuresearch Clinical Consulting Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.